Isothermal microcalorimetry as a quality by design tool to determine optimal blending sequences.
This study was designed to assess the value of isothermal microcalorimetry (ITMC) as a quality by design (QbD) tool to optimize blending conditions during tablet preparation. Powder mixtures that contain microcrystalline cellulose (MCC), dibasic calcium phosphate dihydrate (DCPD), and prednisone were prepared as 1:1:1 ratios using different blending sequences. ITMC was used to monitor the thermal activity of the powder mixtures before and after each blending process. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) were performed on all final powder mixtures. Final powder mixtures were used to prepare tablets with 10 mg prednisone content, and dissolution tests were performed on all tablet formulations. Using ITMC, it was observed that the powder mixtures had different thermal activity depending on the blending sequences of the ingredients. All mixtures prepared by mixing prednisone with DCPD in the first stage were associated with relatively fast and significant heat exchange. In contrast, mixing prednisone with MCC in the first step resulted in slower heat exchange. Powder mixture with high thermal activity showed extra DSC peaks, and their dissolution was generally slower compared to the other tablets. Blending is considered as a critical parameter in tablet preparation. This study showed that ITMC is a simple and efficient tool to monitor solid-state reactions between excipients and prednisone depending on blending sequences. ITMC has the potential to be used in QbD approaches to optimize blending parameters for prednisone tablets.
Al-Hallak
M H D Kamal
MH
Faculty of Pharmacy and Pharmaceutical Sciences, 3126 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta T6G2N8, Canada.
Azarmi
Shirzad
S
Xu
Zhenghe
Z
Maham
Yadollah
Y
Löbenberg
Raimar
R
D002151:Calorimetry / Q000379:methods*; D010316:Particle Size; D012995:Solubility; D013607:Tablets; D014961:X-Ray Diffraction
D013607:Tablets
Eur J Pharm Sci. 2001 May;13(2):123-33
11297896
Analyst. 2008 Jan;133(1):58-64
18087614
Curr Pharm Biotechnol. 2005 Jun;6(3):193-203
15974974
AAPS J. 2008 Jun;10(2):268-76
18465252
Int J Pharm. 1999 Jul 20;184(2):199-206
10387949
Eur J Pharm Biopharm. 2007 Jun;66(3):466-74
17257816
J Pharm Sci. 2008 Oct;97(10):4485-97
18271036
Pharm Res. 2008 Apr;25(4):781-91
18185986
Int J Pharm. 2007 Jan 2;328(1):12-21
17084051
J Pharm Sci. 2006 Aug;95(8):1641-65
16802362
Anal Chem. 1996 Feb 1;68(3):509-13
21619087
Int J Pharm. 1999 Mar 15;179(2):141-58
10053210
Curr Pharm Biotechnol. 2005 Jun;6(3):181-91
15974973